Danish drug major Novo Nordisk has received US Food and Drug Administration (FDA) approval to sell its blockbuster weight loss drug Wegovy (semaglutide 25 mg) as once a day oral pill in that country.

According to Sherrie, the Switch-On Diet is a four-week programme developed by a Korean doctor and is designed to activate the body’s fat-burning mechanism. According to a New York Times report, the ...

A recent study was conducted by Pakhale and colleagues to determine whether weight reduction by dieting could ameliorate airway hyperresponsiveness (AHR), a characteristic and quantifiable feature of ...

Weight Watchers has unveiled a fresh service aimed at helping individuals on GLP-1 medications such as Ozempic or Wegovy maintain their weight loss. The new members' package offers coaching, ...

In the context of the global obesity epidemic, the FDA approved several glucagon-like peptide-1 (GLP-1) receptor agonists (GPL-1RAs), such as liraglutide (Saxenda) and semaglutide (Ozempic, Wegovy) as ...

Please provide your email address to receive an email when new articles are posted on . Of adults who did not lose 5% of their weight with tirzepatide at 12 weeks, 90% achieved 5% weight loss at 72 ...

Background: Population-based studies have documented an association between obesity and an increased prevalence of asthma in women. Methods: We prospectively studied 58 obese women with a body mass ...

Eli Lilly and Company, along with partner institutions in the US and United Kingdom, describe how short-term pharmacologic intervention does not appear to have lasting effects for most tirzepatide ...